Comparison of the Metabolic Effects of Ritonavir-Boosted Darunavir or Atazanavir Versus Raltegravir, and the Impact of Ritonavir Plasma Exposure: ACTG 5257
Ighovwerha Ofotokun(Emory University), M. Adams, Randi Y. Leavitt(Merck & Co., Inc., Rahway, NJ, USA (United States)), Angelina Villası́s-Keever(Bristol-Myers Squibb (United States)), Frain Jb, Heather J. Ribaudo(Cancer Research And Biostatistics), B. Taiwo, Jeffrey L. Lennox(Emory University), M. Palmer, J. Baer, Catherine Godfrey(United States Department of State), M. Dube(Goddard Space Flight Center), E. Seefried, M. Saemann, Manish Sagar(Evidence (Italy)), Raphael J. Landovitz(APLA Health), Susan E. Cohn(Brigham and Women's Hospital), Daniel R. Kuritzkes(Brigham and Women's Hospital), T. Spitz, Bryan Baugh(Brigham and Women's Hospital), C. Basler, Francesca Aweeka(University of California, San Francisco), Todd T. Brown(Johns Hopkins University), B. Santos, E. Lindsey, L. Meixner, A. Thomas, Judith S. Currier(University of California, Los Angeles), V. BAILEY, B. Putnam, Daar Es, S A Shaik, Michael F. Para(The Ohio State University), Kristine B. Patterson(University of North Carolina at Chapel Hill), Lumine H Na(Harvard University), F. Moran, T. James, P. Tebas, R. Basham, I. B. Dueno, R. Bedimo, B. Berzins, E. Chang, D. Currin, D. Cohn, M. Mba, J. L. S. Bagur, Grace A. McComsey(University Hospitals of Cleveland), M. Chicurel-Bayard, SL Koletar
Cited by 82
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
|New England Journal of Medicine|2020|1.4k
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k
SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|981
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891